category stringclasses 14
values | citation stringlengths 17 27 | dea_code_number stringdate 1100-01-01 00:00:00 9873-01-01 00:00:00 β | derived_fields listlengths 1 1 | id stringlengths 5 80 | schedule stringclasses 5
values | source stringclasses 1
value | source_quote stringlengths 14 802 | substance_name stringlengths 5 654 | url stringlengths 76 151 | verified_fields listlengths 3 5 | scope_qualifier stringclasses 18
values | temporary_expiry stringclasses 6
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Temporary listing of substances subject to emergency scheduling | 21 CFR 1308.11(h)(92) | 9097 | [
"citation"
] | 1-1-1-4-bromophenyl-ethyl-piperidin-4-yl-5-6-dichloro-1-3-dihydro-2h-benzo-d-imi | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (92) 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968) | 9097 | | 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-1-4-bromophenyl-ethyl-piperidin-4-yl-5-6-dichloro-1-3-dihydro-2h-benzo-d-imi/ | [
"category",
"dea_code_number",
"schedule",
"substance_name",
"temporary_expiry"
] | null | Aug. 27, 2028 |
Hallucinogenic substances | 21 CFR 1308.11(d)(35) | 7473 | [
"citation"
] | 1-1-2-thienyl-cyclohexyl-pyrrolidine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (35) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine | 7473 | | 1-[1-(2-thienyl)cyclohexyl]pyrrolidine | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-2-thienyl-cyclohexyl-pyrrolidine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(105) | 7552 | [
"citation"
] | 1-1-3-benzodioxol-5-yl-2-dimethylamino-pentan-1-one-other-names-dipentylone-n-n- | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (105) 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone) | 7552 | | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-3-benzodioxol-5-yl-2-dimethylamino-pentan-1-one-other-names-dipentylone-n-n-/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(101) | 7549 | [
"citation"
] | 1-1-3-benzodioxol-5-yl-2-ethylamino-butan-1-one-other-names-eutylone-bk-ebdb | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (101) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB) | 7549 | | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-3-benzodioxol-5-yl-2-ethylamino-butan-1-one-other-names-eutylone-bk-ebdb/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(80) | 7547 | [
"citation"
] | 1-1-3-benzodioxol-5-yl-2-ethylamino-propan-1-one-ethylone | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (80) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone) | 7547 | | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-3-benzodioxol-5-yl-2-ethylamino-propan-1-one-ethylone/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(62) | 7541 | [
"citation"
] | 1-1-3-benzodioxol-5-yl-2-methylamino-butan-1-one-butylone-bk-mbdb | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (62) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB) | (7541) | | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-3-benzodioxol-5-yl-2-methylamino-butan-1-one-butylone-bk-mbdb/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(64) | 7542 | [
"citation"
] | 1-1-3-benzodioxol-5-yl-2-methylamino-pentan-1-one-pentylone-bk-mbdp | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (64) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP) | (7542) | | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-1-3-benzodioxol-5-yl-2-methylamino-pentan-1-one-pentylone-bk-mbdp/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(83) | 7089 | [
"citation"
] | 1-4-cyanobutyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-4-cn- | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (83) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78) | 7089 | | 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-4-cyanobutyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-4-cn-/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(93) | 7014 | [
"citation"
] | 1-4-fluorobenzyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-other-na | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (93) (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144) | 7014 | | (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-4-fluorobenzyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-other-na/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(88) | 1245 | [
"citation"
] | 1-4-methoxyphenyl-n-methylpropan-2-amine-other-names-para-methoxymethamphetamine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (88) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA) | (1245) | | 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-4-methoxyphenyl-n-methylpropan-2-amine-other-names-para-methoxymethamphetamine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(49) | 7011 | [
"citation"
] | 1-5-fluoro-pentyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-5-fluor | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (49) [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11) | (7011) | | [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-5-fluoro-pentyl-1h-indol-3-yl-2-2-3-3-tetramethylcyclopropyl-methanone-5-fluor/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(108) | 7201 | [
"citation"
] | 1-5-fluoropentyl-3-1-naphthoyl-indole-am2201 | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (108) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) | 7201 | | 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-5-fluoropentyl-3-1-naphthoyl-indole-am2201/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(92) | 7083 | [
"citation"
] | 1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-5f- | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (92) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) | 7083 | | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-indazole-3-carboxamide-other-names-5f-/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(85) | 7085 | [
"citation"
] | 1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-pyrrolo-2-3-b-pyridine-3-carboxamide-o | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (85) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA) | 7085 | | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-5-fluoropentyl-n-2-phenylpropan-2-yl-1h-pyrrolo-2-3-b-pyridine-3-carboxamide-o/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(3) | null | [
"citation"
] | 1-androstenediol-3-17-dihydroxy-5-androst-1-ene | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (3) 1-androstenediol (3Ξ²,17Ξ²-dihydroxy-5Ξ±-androst-1-ene); | 1-androstenediol (3Ξ²,17Ξ²-dihydroxy-5Ξ±-androst-1-ene) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-androstenediol-3-17-dihydroxy-5-androst-1-ene/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(4) | null | [
"citation"
] | 1-androstenediol-3-17-dihydroxy-5-androst-1-ene-2 | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (4) 1-androstenediol (3Ξ±,17Ξ²-dihydroxy-5Ξ±-androst-1-ene); | 1-androstenediol (3Ξ±,17Ξ²-dihydroxy-5Ξ±-androst-1-ene) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-androstenediol-3-17-dihydroxy-5-androst-1-ene-2/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(7) | null | [
"citation"
] | 1-androstenedione-5-androst-1-en-3-17-dione | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (7) 1-androstenedione (5Ξ±-androst-1-en-3,17-dione); | 1-androstenedione (5Ξ±-androst-1-en-3,17-dione) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-androstenedione-5-androst-1-en-3-17-dione/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(67) | 1258 | [
"citation"
] | 1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one-naphyrone | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (67) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone) | (1258) | | 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one-naphyrone/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(107) | 7118 | [
"citation"
] | 1-pentyl-3-1-naphthoyl-indole-jwh-018-and-am678 | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (107) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) | 7118 | | 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-pentyl-3-1-naphthoyl-indole-jwh-018-and-am678/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Immediate precursors | 21 CFR 1308.12(g)(2)(i) | 7460 | [
"citation"
] | 1-phenylcyclohexylamine | Schedule II | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (i) 1-phenylcyclohexylamine | 7460 | | 1-phenylcyclohexylamine | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-phenylcyclohexylamine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Immediate precursors | 21 CFR 1308.12(g)(2)(ii) | 8603 | [
"citation"
] | 1-piperidinocyclohexanecarbonitrile-pcc | Schedule II | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (ii) 1-piperidinocyclohexanecarbonitrile (PCC) | 8603 | | 1-piperidinocyclohexanecarbonitrile (PCC) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/1-piperidinocyclohexanecarbonitrile-pcc/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Temporary listing of substances subject to emergency scheduling | 21 CFR 1308.11(h)(79) | 9770 | [
"citation"
] | 2-2-2-3-dihydrobenzofuran-5-yl-methyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylet | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (79) 2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene) | 9770 | | 2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-2-3-dihydrobenzofuran-5-yl-methyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylet/ | [
"category",
"dea_code_number",
"schedule",
"substance_name",
"temporary_expiry"
] | null | Oct. 15, 2027 |
Opiates | 21 CFR 1308.11(b)(42) | 9765 | [
"citation"
] | 2-2-4-ethoxybenzyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-other-names-eto | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (42) 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene) | 9765 | | 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-4-ethoxybenzyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-other-names-eto/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Temporary listing of substances subject to emergency scheduling | 21 CFR 1308.11(h)(81) | 9767 | [
"citation"
] | 2-2-4-ethoxybenzyl-5-methyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-its-is | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (81) 2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene) | 9767 | | 2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-4-ethoxybenzyl-5-methyl-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine-its-is/ | [
"category",
"dea_code_number",
"schedule",
"substance_name",
"temporary_expiry"
] | null | Oct. 15, 2027 |
Temporary listing of substances subject to emergency scheduling | 21 CFR 1308.11(h)(82) | 9768 | [
"citation"
] | 2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-ethylethan-1-amine-its-isomers | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (82) 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene) | 9768 | | 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-ethylethan-1-amine-its-isomers/ | [
"category",
"dea_code_number",
"schedule",
"substance_name",
"temporary_expiry"
] | null | Oct. 15, 2027 |
Temporary listing of substances subject to emergency scheduling | 21 CFR 1308.11(h)(84) | 9771 | [
"citation"
] | 2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-n-dimethylethan-1-amine-its-is | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (84) 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene) | 9771 | | 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-4-ethoxybenzyl-5-nitro-1h-benzimidazol-1-yl-n-n-dimethylethan-1-amine-its-is/ | [
"category",
"dea_code_number",
"schedule",
"substance_name",
"temporary_expiry"
] | null | Oct. 15, 2027 |
Hallucinogenic substances | 21 CFR 1308.11(d)(38) | 7509 | [
"citation"
] | 2-2-5-dimethoxy-4-ethylphenyl-ethanamine-2c-e | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) | 7509 | | 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-5-dimethoxy-4-ethylphenyl-ethanamine-2c-e/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(39) | 7508 | [
"citation"
] | 2-2-5-dimethoxy-4-methylphenyl-ethanamine-2c-d | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) | 7508 | | 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-5-dimethoxy-4-methylphenyl-ethanamine-2c-d/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(46) | 7524 | [
"citation"
] | 2-2-5-dimethoxy-4-n-propylphenyl-ethanamine-2c-p | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) | 7524 | | 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-5-dimethoxy-4-n-propylphenyl-ethanamine-2c-p/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(45) | 7521 | [
"citation"
] | 2-2-5-dimethoxy-4-nitro-phenyl-ethanamine-2c-n | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) | 7521 | | 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-5-dimethoxy-4-nitro-phenyl-ethanamine-2c-n/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(44) | 7517 | [
"citation"
] | 2-2-5-dimethoxyphenyl-ethanamine-2c-h | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (44) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) | 7517 | | 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-5-dimethoxyphenyl-ethanamine-2c-h/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Temporary listing of substances subject to emergency scheduling | 21 CFR 1308.11(h)(80) | 9766 | [
"citation"
] | 2-2-benzodioxol-5-ylmethyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (80) 2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3β²,4β²-methylenedioxynitazene) | 9766 | | 2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3β²,4β²-methylenedioxynitazene) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-2-benzodioxol-5-ylmethyl-5-nitro-1h-benzimidazol-1-yl-n-n-diethylethan-1-amine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name",
"temporary_expiry"
] | null | Oct. 15, 2027 |
Anabolic steroids | 21 CFR 1308.13(f)(29) | null | [
"citation"
] | 2-3-epithio-17-methyl-5-androstan-17-ol | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (29) 2Ξ±,3Ξ±-epithio-17Ξ±-methyl-5Ξ±-androstan-17Ξ²-ol; | 2Ξ±,3Ξ±-epithio-17Ξ±-methyl-5Ξ±-androstan-17Ξ²-ol | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-3-epithio-17-methyl-5-androstan-17-ol/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(57) | 7536 | [
"citation"
] | 2-4-bromo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25b-nbome-2c-b-nbome | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (57) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe) | (7536) | | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-bromo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25b-nbome-2c-b-nbome/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(40) | 7519 | [
"citation"
] | 2-4-chloro-2-5-dimethoxyphenyl-ethanamine-2c-c | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) | 7519 | | 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-chloro-2-5-dimethoxyphenyl-ethanamine-2c-c/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(56) | 7537 | [
"citation"
] | 2-4-chloro-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25c-nbome-2c-c-nbome | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (56) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe) | (7537) | | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-chloro-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25c-nbome-2c-c-nbome/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Opiates | 21 CFR 1308.11(b)(78) | 9758 | [
"citation"
] | 2-4-ethoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names- | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (78) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne) | 9758 | | 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-ethoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names-/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(42) | 7385 | [
"citation"
] | 2-4-ethylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-2 | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) | 7385 | | 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-ethylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-2/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(41) | 7518 | [
"citation"
] | 2-4-iodo-2-5-dimethoxyphenyl-ethanamine-2c-i | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) | 7518 | | 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-iodo-2-5-dimethoxyphenyl-ethanamine-2c-i/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(55) | 7538 | [
"citation"
] | 2-4-iodo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25i-nbome-2c-i-nbome | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (55) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe) | (7538) | | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-iodo-2-5-dimethoxyphenyl-n-2-methoxybenzyl-ethanamine-25i-nbome-2c-i-nbome/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Temporary listing of substances subject to emergency scheduling | 21 CFR 1308.11(h)(85) | 9772 | [
"citation"
] | 2-4-isopropoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-its-isom | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (85) 2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene) | 9772 | | 2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-isopropoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-its-isom/ | [
"category",
"dea_code_number",
"schedule",
"substance_name",
"temporary_expiry"
] | null | Oct. 15, 2027 |
Hallucinogenic substances | 21 CFR 1308.11(d)(43) | 7532 | [
"citation"
] | 2-4-isopropylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-4 | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) | 7532 | | 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-isopropylthio-2-5-dimethoxyphenyl-ethanamine-2c-t-4/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Opiates | 21 CFR 1308.11(b)(79) | 9762 | [
"citation"
] | 2-4-methoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (79) 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne) | 9762 | | 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-4-methoxybenzyl-5-nitro-1-2-pyrrolidin-1-yl-ethyl-1h-benzimidazole-other-names/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(5) | 7399 | [
"citation"
] | 2-5-dimethoxy-4-ethylamphet-amine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (5) 2,5-dimethoxy-4-ethylamphet-amine | 7399 | | 2,5-dimethoxy-4-ethylamphet-amine | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-5-dimethoxy-4-ethylamphet-amine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(6) | 7348 | [
"citation"
] | 2-5-dimethoxy-4-n-propylthiophenethylamine-other-name-2c-t-7 | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) | 7348 | | 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-5-dimethoxy-4-n-propylthiophenethylamine-other-name-2c-t-7/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(4) | 7396 | [
"citation"
] | 2-5-dimethoxyamphetamine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (4) 2,5-dimethoxyamphetamine | 7396 | | 2,5-dimethoxyamphetamine | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-5-dimethoxyamphetamine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Opiates | 21 CFR 1308.11(b)(37) | 9861 | [
"citation"
] | 2-5-dimethoxyfentanyl-n-1-2-5-dimethoxyphenethyl-piperidin-4-yl-n-phenylpropiona | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (37) 2β²,5β²-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) | 9861 | | 2β²,5β²-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-5-dimethoxyfentanyl-n-1-2-5-dimethoxyphenethyl-piperidin-4-yl-n-phenylpropiona/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(27) | null | [
"citation"
] | 2-17-dimethyl-17-hydroxy-5-androstan-3-one | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (27) 2Ξ±,17Ξ±-dimethyl-17Ξ²-hydroxy-5Ξ²-androstan-3-one; | 2Ξ±,17Ξ±-dimethyl-17Ξ²-hydroxy-5Ξ²-androstan-3-one | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-17-dimethyl-17-hydroxy-5-androstan-3-one/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Narcotic drugs | 21 CFR 1308.14(b)(3) | 9752 | [
"citation"
] | 2-dimethylamino-methyl-1-3-methoxyphenyl-cyclohexanol-its-salts-optical-and-geom | Schedule IV | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) | 9752 | | 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-dimethylamino-methyl-1-3-methoxyphenyl-cyclohexanol-its-salts-optical-and-geom/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(100) | 7286 | [
"citation"
] | 2-ethylamino-2-3-methoxyphenyl-cyclohexan-1-one-methoxetamine-mxe | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (100) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE) | 7286 | | 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-ethylamino-2-3-methoxyphenyl-cyclohexan-1-one-methoxetamine-mxe/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Opiates | 21 CFR 1308.11(b)(48) | 9855 | [
"citation"
] | 2-fluoro-ortho-fluorofentanyl-n-1-2-fluorophenethyl-piperidin-4-yl-n-2-fluorophe | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (48) 2β²-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2β²-fluoro 2-fluorofentanyl) | 9855 | | 2β²-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2β²-fluoro 2-fluorofentanyl) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-fluoro-ortho-fluorofentanyl-n-1-2-fluorophenethyl-piperidin-4-yl-n-2-fluorophe/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Temporary listing of substances subject to emergency scheduling | 21 CFR 1308.11(h)(87) | 7284 | [
"citation"
] | 2-fluorodeschloroketamine-its-salts-isomers-and-salts-of-isomers-other-name-2-2- | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (87) 2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK) | 7284 | | 2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-fluorodeschloroketamine-its-salts-isomers-and-salts-of-isomers-other-name-2-2-/ | [
"category",
"dea_code_number",
"schedule",
"substance_name",
"temporary_expiry"
] | null | May 22, 2028 |
Opiates | 21 CFR 1308.11(b)(64) | 9664 | [
"citation"
] | 2-methyl-ap-237-1-2-methyl-4-3-phenylprop-2-en-1-yl-piperazin-1-yl-butan-1-one | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (64) 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) | 9664 | | 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-methyl-ap-237-1-2-methyl-4-3-phenylprop-2-en-1-yl-piperazin-1-yl-butan-1-one/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(104) | 1259 | [
"citation"
] | 2-methylamino-1-3-methylphenyl-propan-1-one-other-names-3-mmc-3-methylmethcathin | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (104) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone) | 1259 | | 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-methylamino-1-3-methylphenyl-propan-1-one-other-names-3-mmc-3-methylmethcathin/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(63) | 1246 | [
"citation"
] | 2-methylamino-1-phenylpentan-1-one-pentedrone | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (63) 2-(methylamino)-1-phenylpentan-1-one (pentedrone) | (1246) | | 2-(methylamino)-1-phenylpentan-1-one (pentedrone) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/2-methylamino-1-phenylpentan-1-one-pentedrone/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Temporary listing of substances subject to emergency scheduling | 21 CFR 1308.11(h)(94) | 9094 | [
"citation"
] | 3-3-1-1-4-chlorophenyl-ethyl-piperidin-4-yl-2-oxo-2-3-dihydro-1h-benzo-d-imidazo | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (94) 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine) | 9094 | | 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-3-1-1-4-chlorophenyl-ethyl-piperidin-4-yl-2-oxo-2-3-dihydro-1h-benzo-d-imidazo/ | [
"category",
"dea_code_number",
"schedule",
"substance_name",
"temporary_expiry"
] | null | Aug. 27, 2028 |
Hallucinogenic substances | 21 CFR 1308.11(d)(14) | 7390 | [
"citation"
] | 3-4-5-trimethoxy-amphetamine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (14) 3,4,5-trimethoxy amphetamine | 7390 | | 3,4,5-trimethoxy amphetamine | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-5-trimethoxy-amphetamine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(10) | 7400 | [
"citation"
] | 3-4-methylenedioxy-amphetamine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (10) 3,4-methylenedioxy amphetamine | 7400 | | 3,4-methylenedioxy amphetamine | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-methylenedioxy-amphetamine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(12) | 7404 | [
"citation"
] | 3-4-methylenedioxy-n-ethylamphetamine-also-known-as-n-ethyl-alpha-methyl-3-4-met | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA | 7404 | | 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-methylenedioxy-n-ethylamphetamine-also-known-as-n-ethyl-alpha-methyl-3-4-met/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(47) | 7540 | [
"citation"
] | 3-4-methylenedioxy-n-methylcathinone-methylone | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (47) 3,4-Methylenedioxy-N-methylcathinone (Methylone) | 7540 | | 3,4-Methylenedioxy-N-methylcathinone (Methylone) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-methylenedioxy-n-methylcathinone-methylone/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(11) | 7405 | [
"citation"
] | 3-4-methylenedioxymethamphetamine-mdma | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (11) 3,4-methylenedioxymethamphetamine (MDMA) | 7405 | | 3,4-methylenedioxymethamphetamine (MDMA) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-methylenedioxymethamphetamine-mdma/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(37) | 7535 | [
"citation"
] | 3-4-methylenedioxypyrovalerone-mdpv | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (37) 3,4-methylenedioxypyrovalerone (MDPV) | 7535 | | 3,4-methylenedioxypyrovalerone (MDPV) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-4-methylenedioxypyrovalerone-mdpv/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(25) | null | [
"citation"
] | 3-17-dihydroxy-5-androstane | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (25) 3Ξ²,17Ξ²-dihydroxy-5Ξ±-androstane; | 3Ξ²,17Ξ²-dihydroxy-5Ξ±-androstane | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-17-dihydroxy-5-androstane/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(26) | null | [
"citation"
] | 3-17-dihydroxy-5-androstane-2 | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (26) 3Ξ±,17Ξ²-dihydroxy-5Ξ±-androstane; | 3Ξ±,17Ξ²-dihydroxy-5Ξ±-androstane | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-17-dihydroxy-5-androstane-2/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(66) | 1233 | [
"citation"
] | 3-fluoro-n-methylcathinone-3-fmc | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (66) 3-fluoro-N-methylcathinone (3-FMC) | (1233) | | 3-fluoro-N-methylcathinone (3-FMC) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-fluoro-n-methylcathinone-3-fmc/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Opiates | 21 CFR 1308.11(b)(50) | 9860 | [
"citation"
] | 3-furanyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylfuran-3-carboxamide | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (50) 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) | 9860 | | 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-furanyl-fentanyl-n-1-phenethylpiperidin-4-yl-n-phenylfuran-3-carboxamide/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(42) | null | [
"citation"
] | 3-hydroxy-estra-4-9-11-trien-17-one | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (42) 3Ξ²-hydroxy-estra-4,9,11-trien-17-one; | 3Ξ²-hydroxy-estra-4,9,11-trien-17-one | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-hydroxy-estra-4-9-11-trien-17-one/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(109) | 7457 | [
"citation"
] | 3-methoxyphencyclidine-other-names-1-1-3-methoxyphenyl-cyclohexyl-piperidine-3-m | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (109) 3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP) | 7457 | | 3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-methoxyphencyclidine-other-names-1-1-3-methoxyphenyl-cyclohexyl-piperidine-3-m/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Opiates | 21 CFR 1308.11(b)(65) | 9813 | [
"citation"
] | 3-methylfentanyl-n-3-methyl-1-2-phenylethyl-4-piperidyl-n-phenylpropanamide | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (65) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) | 9813 | | 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-methylfentanyl-n-3-methyl-1-2-phenylethyl-4-piperidyl-n-phenylpropanamide/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Opiates | 21 CFR 1308.11(b)(66) | 9833 | [
"citation"
] | 3-methylthiofentanyl-n-3-methyl-1-2-thienylethyl-4-piperidinyl-n-phenylpropanami | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (66) 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide) | 9833 | | 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/3-methylthiofentanyl-n-3-methyl-1-2-thienylethyl-4-piperidinyl-n-phenylpropanami/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Stimulants | 21 CFR 1308.11(f)(5) | 1595 | [
"citation"
] | 4-4-dimethylaminorex-4-4-dmar-4-5-dihydro-4-methyl-5-4-methylphenyl-2-oxazolamin | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (5) 4,4β²-Dimethylaminorex (4,4β²-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) | 1595 | | 4,4β²-Dimethylaminorex (4,4β²-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-4-dimethylaminorex-4-4-dmar-4-5-dihydro-4-methyl-5-4-methylphenyl-2-oxazolamin/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(5) | null | [
"citation"
] | 4-androstenediol-3-17-dihydroxy-androst-4-ene | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (5) 4-androstenediol (3Ξ²,17Ξ²-dihydroxy-androst-4-ene); | 4-androstenediol (3Ξ²,17Ξ²-dihydroxy-androst-4-ene) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-androstenediol-3-17-dihydroxy-androst-4-ene/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(8) | null | [
"citation"
] | 4-androstenedione-androst-4-en-3-17-dione | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (8) 4-androstenedione (androst-4-en-3,17-dione); | 4-androstenedione (androst-4-en-3,17-dione) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-androstenedione-androst-4-en-3-17-dione/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Immediate precursors | 21 CFR 1308.12(g)(3)(i) | 8333 | [
"citation"
] | 4-anilino-n-phenethylpiperidine-anpp | Schedule II | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (i) 4-anilino-N-phenethylpiperidine (ANPP) | 8333 | | 4-anilino-N-phenethylpiperidine (ANPP) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-anilino-n-phenethylpiperidine-anpp/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(2) | 7391 | [
"citation"
] | 4-bromo-2-5-dimethoxy-amphetamine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (2) 4-bromo-2,5-dimethoxy-amphetamine | 7391 | | 4-bromo-2,5-dimethoxy-amphetamine | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-bromo-2-5-dimethoxy-amphetamine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(3) | 7392 | [
"citation"
] | 4-bromo-2-5-dimethoxyphenethylamine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (3) 4-Bromo-2,5-dimethoxyphenethylamine | 7392 | | 4-Bromo-2,5-dimethoxyphenethylamine | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-bromo-2-5-dimethoxyphenethylamine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(18) | null | [
"citation"
] | 4-chloro-17-methyl-17-hydroxy-androst-4-en-3-one | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (18) 4-chloro-17Ξ±-methyl-17Ξ²-hydroxy-androst-4-en-3-one; | 4-chloro-17Ξ±-methyl-17Ξ²-hydroxy-androst-4-en-3-one | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloro-17-methyl-17-hydroxy-androst-4-en-3-one/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(19) | null | [
"citation"
] | 4-chloro-17-methyl-17-hydroxy-androst-4-ene-3-11-dione | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (19) 4-chloro-17Ξ±-methyl-17Ξ²-hydroxy-androst-4-ene-3,11-dione; | 4-chloro-17Ξ±-methyl-17Ξ²-hydroxy-androst-4-ene-3,11-dione | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloro-17-methyl-17-hydroxy-androst-4-ene-3-11-dione/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(17) | null | [
"citation"
] | 4-chloro-17-methyl-androst-4-ene-3-17-diol | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (17) 4-chloro-17Ξ±-methyl-androst-4-ene-3Ξ²,17Ξ²-diol; | 4-chloro-17Ξ±-methyl-androst-4-ene-3Ξ²,17Ξ²-diol | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloro-17-methyl-androst-4-ene-3-17-diol/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(16) | null | [
"citation"
] | 4-chloro-17-methyl-androsta-1-4-diene-3-17-diol | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (16) 4-chloro-17Ξ±-methyl-androsta-1,4-diene-3,17Ξ²-diol; | 4-chloro-17Ξ±-methyl-androsta-1,4-diene-3,17Ξ²-diol | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloro-17-methyl-androsta-1-4-diene-3-17-diol/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(99) | 7443 | [
"citation"
] | 4-chloro-alpha-pyrrolidinovalerophenone-other-names-4-chloro-pvp-4-chloro-pyrrol | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (99) 4β²-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-Ξ±-PVP; 4β²-chloro-Ξ±-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one) | 7443 | | 4β²-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-Ξ±-PVP; 4β²-chloro-Ξ±-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloro-alpha-pyrrolidinovalerophenone-other-names-4-chloro-pvp-4-chloro-pyrrol/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(106) | 1239 | [
"citation"
] | 4-chloromethcathinone-4-cmc-1-4-chlorophenyl-2-methylamino-propan-1-one | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (106) 4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one) | 1239 | | 4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-chloromethcathinone-4-cmc-1-4-chlorophenyl-2-methylamino-propan-1-one/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(23) | null | [
"citation"
] | 4-dihydrotestosterone-17-hydroxy-androstan-3-one | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (23) 4-dihydrotestosterone (17Ξ²-hydroxy-androstan-3-one); | 4-dihydrotestosterone (17Ξ²-hydroxy-androstan-3-one) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-dihydrotestosterone-17-hydroxy-androstan-3-one/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(65) | 1238 | [
"citation"
] | 4-fluoro-n-methylcathinone-4-fmc-flephedrone | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (65) 4-fluoro-N-methylcathinone (4-FMC; flephedrone) | (1238) | | 4-fluoro-N-methylcathinone (4-FMC; flephedrone) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-fluoro-n-methylcathinone-4-fmc-flephedrone/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Stimulants | 21 CFR 1308.11(f)(8) | 1476 | [
"citation"
] | 4-fluoroamphetamine-4-fa-1-4-fluorophenyl-propan-2-amine-para-fluoroamphetamine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (8) 4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine) | 1476 | | 4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-fluoroamphetamine-4-fa-1-4-fluorophenyl-propan-2-amine-para-fluoroamphetamine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Opiates | 21 CFR 1308.11(b)(47) | 9824 | [
"citation"
] | 4-fluoroisobutyryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-isobuty | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (47) 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl) | 9824 | | 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-fluoroisobutyryl-fentanyl-n-4-fluorophenyl-n-1-phenethylpiperidin-4-yl-isobuty/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(38) | null | [
"citation"
] | 4-hydroxy-19-nortestosterone-4-17-dihydroxy-estr-4-en-3-one | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (38) 4-hydroxy-19-nortestosterone (4,17Ξ²-dihydroxy-estr-4-en-3-one); | 4-hydroxy-19-nortestosterone (4,17Ξ²-dihydroxy-estr-4-en-3-one) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-hydroxy-19-nortestosterone-4-17-dihydroxy-estr-4-en-3-one/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(39) | null | [
"citation"
] | 4-hydroxy-androst-4-ene-3-17-dione | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (39) 4-hydroxy-androst-4-ene-3,17-dione; | 4-hydroxy-androst-4-ene-3,17-dione | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-hydroxy-androst-4-ene-3-17-dione/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Anabolic steroids | 21 CFR 1308.13(f)(43) | null | [
"citation"
] | 4-hydroxytestosterone-4-17-dihydroxy-androst-4-en-3-one | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (43) 4-hydroxytestosterone (4,17Ξ²-dihydroxy-androst-4-en-3-one); | 4-hydroxytestosterone (4,17Ξ²-dihydroxy-androst-4-en-3-one) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-hydroxytestosterone-4-17-dihydroxy-androst-4-en-3-one/ | [
"category",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(7) | 7411 | [
"citation"
] | 4-methoxyamphetamine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (7) 4-methoxyamphetamine | 7411 | | 4-methoxyamphetamine | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methoxyamphetamine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(103) | 7551 | [
"citation"
] | 4-methyl-1-phenyl-2-pyrrolidin-1-yl-pentan-1-one-other-names-pihp-alpha-pihp | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (103) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: Ξ±-PiHP; alpha-PiHP) | 7551 | | 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: Ξ±-PiHP; alpha-PiHP) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-1-phenyl-2-pyrrolidin-1-yl-pentan-1-one-other-names-pihp-alpha-pihp/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(9) | 7395 | [
"citation"
] | 4-methyl-2-5-dimethoxy-amphetamine | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (9) 4-methyl-2,5-dimethoxy-amphetamine | 7395 | | 4-methyl-2,5-dimethoxy-amphetamine | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-2-5-dimethoxy-amphetamine/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Opiates | 21 CFR 1308.11(b)(63) | 9819 | [
"citation"
] | 4-methyl-acetyl-fentanyl-n-1-4-methylphenethyl-piperidin-4-yl-n-phenylacetamide | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (63) 4β²-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) | 9819 | | 4β²-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-acetyl-fentanyl-n-1-4-methylphenethyl-piperidin-4-yl-n-phenylacetamide/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(96) | 7245 | [
"citation"
] | 4-methyl-alpha-ethylaminopentiophenone-other-names-4-meap-2-ethylamino-1-4-methy | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (96) 4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) | 7245 | | 4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-alpha-ethylaminopentiophenone-other-names-4-meap-2-ethylamino-1-4-methy/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(97) | 7446 | [
"citation"
] | 4-methyl-alpha-pyrrolidinohexiophenone-other-names-mphp-4-methyl-alpha-pyrrolidi | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (97) 4β²-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4β²-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) | 7446 | | 4β²-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4β²-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-alpha-pyrrolidinohexiophenone-other-names-mphp-4-methyl-alpha-pyrrolidi/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(60) | 7498 | [
"citation"
] | 4-methyl-alpha-pyrrolidinopropiophenone-4-meppp | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (60) 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) | (7498) | | 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-alpha-pyrrolidinopropiophenone-4-meppp/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(59) | 1249 | [
"citation"
] | 4-methyl-n-ethylcathinone-4-mec | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (59) 4-methyl-N-ethylcathinone (4-MEC) | (1249) | | 4-methyl-N-ethylcathinone (4-MEC) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methyl-n-ethylcathinone-4-mec/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Hallucinogenic substances | 21 CFR 1308.11(d)(36) | 1248 | [
"citation"
] | 4-methylmethcathinone-mephedrone | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (36) 4-methylmethcathinone (Mephedrone) | 1248 | | 4-methylmethcathinone (Mephedrone) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/4-methylmethcathinone-mephedrone/ | [
"category",
"dea_code_number",
"schedule",
"substance_name"
] | null | null |
Temporary listing of substances subject to emergency scheduling | 21 CFR 1308.11(h)(93) | 9096 | [
"citation"
] | 5-6-dichloro-1-1-4-chlorobenzyl-piperidin-4-yl-1-3-dihydro-2h-benzo-d-imidazol-2 | Schedule I | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (93) 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018) | 9096 | | 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018) | https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-6-dichloro-1-1-4-chlorobenzyl-piperidin-4-yl-1-3-dihydro-2h-benzo-d-imidazol-2/ | [
"category",
"dea_code_number",
"schedule",
"substance_name",
"temporary_expiry"
] | null | Aug. 27, 2028 |
Anabolic steroids | 21 CFR 1308.13(f)(2) | null | [
"citation"
] | 5-androstan-3-6-17-trione | Schedule III | https://www.ecfr.gov/current/title-21/chapter-II/part-1308 | (2) 5Ξ±-androstan-3,6,17-trione; | 5Ξ±-androstan-3,6,17-trione | https://referencesource.org/dea-controlled-substance-schedule-by-drug/5-androstan-3-6-17-trione/ | [
"category",
"schedule",
"substance_name"
] | null | null |
End of preview. Expand in Data Studio
Federal controlled substance schedule (I-V) by drug, with DEA code number
Canonical, always-current version: https://referencesource.org/dea-controlled-substance-schedule-by-drug/ Machine-readable: https://referencesource.org/dea-controlled-substance-schedule-by-drug/data.json β this mirror is a point-in-time copy.
- Last verified: 2026-09-01
- Stale after: 2026-12-30 (past this date, prefer the canonical copy β it re-verifies on a cadence this snapshot does not)
- Records: 591
Every substance named in the federal drug schedules at 21 CFR 1308.11-1308.15, with the schedule it sits in, its DEA Controlled Substances Code Number, the class it is listed under, and the exact paragraph of the regulation the entry comes from. One record is one substance at one paragraph, quoted from the regulation itself. A drug can sit in more than one schedule at the same time, and the difference is usually the preparation rather than the drug: codeine is Schedule II on its own, Schedule III in a limited-strength compound, and Schedule V at not more than 200 milligrams per 100 millilitres. Each of those is a separate record, so the answer is not silently collapsed into whichever listing came first. Marijuana is split the same way: Schedule I as a plant, and Schedule III in an FDA-approved product or when subject to a state medical marijuana licence. Substances placed in Schedule I on an emergency temporary basis carry the date that placement runs until, with one deliberate exception. Fentanyl-related substances at 1308.11(h)(30) are left blank: the regulation's own Effective Date Note ends with Congress extending that paragraph 'until Sept. 30, 2025', a date now past, yet the paragraph is still printed -- because the substances did not stop being Schedule I. Congress put them there permanently on July 16, 2025 by the HALT Fentanyl Act (Public Law 119-26), which added paragraph (e) to Schedule I of 21 U.S.C. 812(c), and 21 CFR 1308.11 does not mention it. Printing 'expires Sept. 30, 2025' against that row would be a verbatim quote of the regulation and would answer the question backwards. Two limits are worth knowing: the anabolic steroids in 1308.13(f) share a single code number for the whole class, so individual steroids are published with no code rather than an invented one, and a few entries print XXXX where a code would go. Answers what schedule a given drug is in, whether marijuana is Schedule I or III, what the DEA code number for a substance is, and when a temporary listing expires.
Provenance β what every record carries
Every record carries source (the URL the value was read from) and
source_quote (a verbatim quote from that page stating it). A value you
cannot check against its page is indistinguishable from an invented one;
these can all be checked. Each record is also individually addressable on
the canonical site at its url.
Licence position
Federal regulatory text (21 CFR), not copyrightable
Facts are not copyrightable; what this dataset takes from each source is a fact plus a short attributed quote linking back to the page that states it.
Sources
Fields
See any record in data/records.jsonl β field names are self-describing,
and the canonical page for each record renders them with labels:
https://referencesource.org/dea-controlled-substance-schedule-by-drug/
- Downloads last month
- 38